United Therapeutic
(UTHR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 547,000 | 82,600 | -16,600 | 340,100 | 224,139 |
| Depreciation Amortization | 25,000 | 23,200 | 11,300 | 32,200 | 37,476 |
| Accounts receivable | -17,400 | -6,900 | 6,100 | -35,700 | -13,324 |
| Accounts payable and accrued liabilities | 25,800 | 23,300 | 4,700 | -6,800 | 35,855 |
| Other Working Capital | -2,100 | -209,500 | -109,600 | -200,500 | -132,986 |
| Other Operating Activity | -221,000 | 237,400 | 213,200 | 226,000 | 113,494 |
| Operating Cash Flow | $357,300 | $150,100 | $109,100 | $355,300 | $264,654 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 169,600 | 111,500 | 72,400 | 430,900 | 376,663 |
| PPE Investments | -18,300 | -7,800 | -4,000 | -47,400 | -45,157 |
| Purchase Of Investment | -54,200 | -4,200 | N/A | -45,000 | -45,000 |
| Purchase Sale Intangibles | 350,000 | 0 | 0 | N/A | N/A |
| Other Investing Activity | 350,000 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $447,100 | $99,500 | $68,400 | $338,500 | $286,506 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 140,000 | 140,000 |
| Debt Repayment | -107,100 | -104,300 | -14,000 | -177,800 | N/A |
| Common Stock Issued | 37,000 | 26,300 | 12,000 | 53,500 | 42,720 |
| Common Stock Repurchased | -394,500 | -336,800 | -152,300 | -483,100 | -403,158 |
| Other Financing Activity | 31,400 | 23,500 | 8,700 | -109,200 | -116,817 |
| Financing Cash Flow | $-433,200 | $-391,300 | $-145,600 | $-576,600 | $-337,255 |
| Exchange Rate Effect | -3,700 | -1,600 | -3,100 | -3,800 | -872 |
| Beginning Cash Position | 397,700 | 397,700 | 397,700 | 284,300 | 284,258 |
| End Cash Position | 765,200 | 254,400 | 426,500 | 397,700 | 497,291 |
| Net Cash Flow | $367,500 | $-143,300 | $28,800 | $113,400 | $213,033 |
| Free Cash Flow | |||||
| Operating Cash Flow | 357,300 | 150,100 | 109,100 | 355,300 | 264,654 |
| Capital Expenditure | -18,300 | -7,800 | -4,000 | -47,400 | -45,157 |
| Free Cash Flow | 339,000 | 142,300 | 105,100 | 307,900 | 219,497 |